| Title: |
Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise: a 12-week, randomized, comparative trial. |
| Authors: |
DeFronzo RA; Bergenstal RM; Cefalu WT; Pullman J; Lerman S; Bode BW; Phillips LS; Exubera Phase III Study Group; DeFronzo, Ralph A; Bergenstal, Richard M; Cefalu, William T; Pullman, John; Lerman, Sam; Bode, Bruce W; Phillips, Lawrence S |
| Source: |
Diabetes Care; Aug2005, Vol. 28 Issue 8, p1922-1928, 7p |
| Abstract: |
Objective: Effective type 2 diabetes management requires prompt intervention if glycemic control is not achieved by nonpharmacological means. This study investigates whether inhaled insulin (INH; Exubera) can achieve target glycemic control in patients failing on diet and exercise.Research Design and Methods: Patients with suboptimal control on diet and exercise (HbA(1c) [A1C] 8-11%) were randomized to 3 months' treatment with either INH before meals (n = 76) or rosiglitazone 4 mg twice a day (n = 69), in conjunction with a diet and exercise regimen. The primary end point was percentage of patients achieving A1C |
| : |
Copyright of Diabetes Care is the property of American Diabetes Association and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |